PVG Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$479K Hold
1,905
0.28% 74
2026
Q1
$422K Sell
1,905
-253
-12% -$56.1K 0.25% 75
2025
Q4
$493K Sell
2,158
-133
-6% -$30.3K 1.05% 28
2025
Q3
$530K Hold
2,291
1.95% 17
2025
Q2
$425K Hold
2,291
1.45% 20
2025
Q1
$480K Sell
2,291
-100
-4% -$19.4K 2.09% 13
2024
Q4
$425K Buy
+2,391
New +$440K 2.01% 20

Other funds holding ABBV

PVG Asset Management's ABBV Position: Q2 2026 in Review

PVG Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,905 shares worth $479K. The position accounts for 0.28% of the portfolio, ranked #74.

PVG Asset Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $530K in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • PVG Asset Management held 1,905 shares of AbbVie worth $479K as of Q2 2026.
  • PVG Asset Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.28% of PVG Asset Management's portfolio in Q2 2026, its #74 holding.
  • PVG Asset Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • PVG Asset Management's AbbVie position peaked at $530K in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on PVG Asset Management's 13F filing for Q2 2026, filed 1 Jul 2026.